Common use of Observer Rights Clause in Contracts

Observer Rights. (a) As long as the ▇. ▇▇▇▇ Price Investors collectively hold at least 2,500,000 shares of Preferred Stock of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of ▇. ▇▇▇▇ Price to attend all meetings of its Board of Directors in a nonvoting observer capacity, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that all information so provided shall be subject to Section 3.5 below and the ▇. ▇▇▇▇ Price Investors shall be responsible for any breaches of Section 3.5 by such representative with respect to such information; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. (b) As long as the Fidelity Investors collectively hold at least 2,500,000 shares of Preferred Stock of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of the Fidelity Investors to attend all meetings of its Board of Directors in a nonvoting observer capacity, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that all information so provided shall be subject to Section 3.5 below and the Fidelity Investors shall be responsible for any breaches of Section 3.5 by such representative with respect to such information; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. (c) As long as Maveron Equity Partners V, L.P. (“Maveron”) holds at least 10,000,000 shares of Preferred Stock of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of Maveron to attend all meetings of its Board of Directors in a nonvoting observer capacity, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that such representative shall agree to hold in confidence and maintain the confidentiality with respect to all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. (d) As long as Tiger Global Private Investment Partners X, L.P. (“Tiger”) holds at least 2,500,000 shares of Preferred Stock of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of Tiger to attend all meetings of its Board of Directors and any and all committees of its Board of Directors (including any Executive Committee, as defined in the Company’s bylaws) in a nonvoting observer capacity, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors and/or committee members; provided, however, that such representative shall agree to hold in confidence and maintain the confidentiality with respect to all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. (e) As long as the Baillie Investors collectively hold at least 500,000 shares of Preferred Stock of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of the Baillie Investors to attend all meetings of its Board of Directors in a nonvoting observer capacity, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that all information so provided shall be subject to Section 3.5 below and the Baillie Investors shall be responsible for any breaches of Section 3.5 by such representative with respect to such information; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. (f) As long as the Franklin Investors collectively hold at least 1,000,000 shares of Preferred Stock of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of the Franklin Investors to attend all meetings of its Board of Directors in a nonvoting observer capacity, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that all information so provided shall be subject to Section 3.5 below and the Franklin Investors shall be responsible for any breaches of Section 3.5 by such representative with respect to such information; provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest.

Appears in 2 contracts

Sources: Investors’ Rights Agreement (Allbirds, Inc.), Investors’ Rights Agreement (Allbirds, Inc.)

Observer Rights. (a) As long as the ▇. ▇▇▇▇ Price Investors collectively hold 5AM Ventures V, L.P., together with its Affiliates (“5AM Ventures”), holds at least 2,500,000 1,000,000 shares of Preferred Common Stock issued or issuable upon conversion of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the likePreferred Stock, the Company shall invite a representative of ▇. ▇▇▇▇ Price 5AM Ventures to attend all meetings of its Board of Directors in a nonvoting observer capacitycapacity and, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors at the same time and in the same manner as provided to such directors; provided, however, that such representative shall agree to hold in confidence and trust with respect to all information so provided shall be subject to Section 3.5 below and (in a manner consistent with the ▇. ▇▇▇▇ Price Investors shall be responsible for any breaches confidentiality obligations of Section 3.5 by such representative with respect to such informationa director of a Delaware corporation); and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if 5AM Ventures or its representative is a competitor of the Company. (b) As long as the Fidelity Investors collectively hold MRL Ventures Fund, LLC, together with its Affiliates (“MRL Ventures”), holds at least 2,500,000 1,000,000 shares of Preferred Common Stock issued or issuable upon conversion of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the likePreferred Stock, the Company shall invite a representative of the Fidelity Investors MRL Ventures to attend all meetings of its Board of Directors in a nonvoting observer capacitycapacity and, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors at the same time and in the same manner as provided to such directors; provided, however, that such representative shall agree to hold in confidence and trust with respect to all information so provided shall be subject to Section 3.5 below and (in a manner consistent with the Fidelity Investors shall be responsible for any breaches confidentiality obligations of Section 3.5 by such representative with respect to such informationa director of a Delaware corporation); and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. (c) As long as Maveron Equity Partners VB▇▇▇▇ Brothers Life Sciences, L.P. and 667, L.P., together with their Affiliates (collectively, the “MaveronBBI Funds”) holds ), hold at least 10,000,000 shares 50% of the Series B Preferred Stock of (or other securities which the Company, which number is subject Series B Preferred Stock may be exchanged or converted into) they purchased pursuant to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the likePurchase Agreement, the Company shall invite a representative of Maveron designated by the BBI Funds to attend all meetings of its Board of Directors in a nonvoting observer capacitycapacity and, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors at the same time and in the same manner as provided to such directors; provided, however, that such representative shall agree to hold in confidence and maintain the confidentiality trust with respect to all information so providedprovided (in a manner consistent with the confidentiality obligations of a director of a Delaware corporation); and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if the BBI Funds or their representative are a competitor of the Company. (d) As long as Tiger Global Private Investment Partners XGreenspring Early Stage I, L.P. L.P., together with its Affiliates (“TigerGreenspring Associates”) ), holds at least 2,500,000 1,000,000 shares of Preferred Common Stock issued or issuable upon conversion of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the likeSeries B Preferred Stock, the Company shall invite a representative of Tiger Greenspring Associates to attend all meetings of its Board of Directors and any and all committees of its Board of Directors (including any Executive Committee, as defined in the Company’s bylaws) in a nonvoting observer capacitycapacity and, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors and/or committee membersat the same time and in the same manner as provided to such directors; provided, however, that such representative shall agree to hold in confidence and maintain the confidentiality trust with respect to all information so providedprovided (in a manner consistent with the confidentiality obligations of a director of a Delaware corporation); and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. (e) As long as the Baillie Investors collectively hold at least 500,000 shares of Preferred Stock , or if Greenspring Associates or its representative is a competitor of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of the Baillie Investors to attend all meetings of its Board of Directors in a nonvoting observer capacity, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that all information so provided shall be subject to Section 3.5 below and the Baillie Investors shall be responsible for any breaches of Section 3.5 by such representative with respect to such information; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. (f) As long as the Franklin Investors collectively hold at least 1,000,000 shares of Preferred Stock of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of the Franklin Investors to attend all meetings of its Board of Directors in a nonvoting observer capacity, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that all information so provided shall be subject to Section 3.5 below and the Franklin Investors shall be responsible for any breaches of Section 3.5 by such representative with respect to such information; provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest.

Appears in 1 contract

Sources: Investors’ Rights Agreement (Entrada Therapeutics, Inc.)

Observer Rights. (a) As For so long as the ▇. ▇Investors affiliated with each of Longitude Venture Partners II, L.P., Quaker Bioventures II, L.P., TVM Capital, Asahi Kasei Medical Co., Ltd., B▇▇▇ Price Investors collectively hold at least 2,500,000 Capital Life Sciences Fund, L.P. (“BCLS”) and D1 Master Holdco I LLC (“D1 Capital”) own not less than 500,000 shares of the Preferred Stock (or an equivalent amount of Common Stock issued upon conversion thereof) (as adjusted for any stock split, stock dividend, combination, or other recapitalization or reclassification effected after the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the likedate hereof), the Company shall invite a one (1) representative of ▇. ▇▇▇▇ Price each such Investor and/or Key Holder (as applicable) to attend all meetings of its the Board of Directors in a nonvoting observer capacitycapacity and, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided. For so long as Investors affiliated with Colony Harvest Ltd (“Colony Harvest”) own, howevercollectively, that all information so provided shall be subject to Section 3.5 below and not less than 500,000 shares of the ▇. ▇▇▇▇ Price Investors shall be responsible Preferred Stock (or an equivalent amount of Common Stock issued upon conversion thereof) (as adjusted for any breaches stock split, stock dividend, combination, or other recapitalization or reclassification effected after the date hereof), the Company shall invite one (1) representative designated by Colony Harvest to attend all meetings of Section 3.5 by the Board in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors. Each representative referred to in the preceding two sentences (each an “Observer”) shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information provided to such information; and provided furtherObserver. Notwithstanding the foregoing, that the Company reserves the right to withhold any information and to exclude any such representative Observer from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. (b) As long as the Fidelity Investors collectively hold at least 2,500,000 shares of Preferred Stock , or if such Investor and/or Key Holder or its Observer is a competitor of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of the Fidelity Investors to attend all meetings of its Board of Directors in a nonvoting observer capacity, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that all information so provided shall be subject to Section 3.5 below and the Fidelity Investors shall be responsible for any breaches of Section 3.5 by such representative with respect to such information; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. (c) As long as Maveron Equity Partners V, L.P. (“Maveron”) holds at least 10,000,000 shares of Preferred Stock of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of Maveron to attend all meetings of its Board of Directors in a nonvoting observer capacity, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that such representative shall agree to hold in confidence and maintain the confidentiality with respect to all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. (d) As long as Tiger Global Private Investment Partners X, L.P. (“Tiger”) holds at least 2,500,000 shares of Preferred Stock of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of Tiger to attend all meetings of its Board of Directors and any and all committees of its Board of Directors (including any Executive Committee, as defined in the Company’s bylaws) in a nonvoting observer capacity, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors and/or committee members; provided, however, that such representative shall agree to hold in confidence and maintain the confidentiality with respect to all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. (e) As long as the Baillie Investors collectively hold at least 500,000 shares of Preferred Stock of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of the Baillie Investors to attend all meetings of its Board of Directors in a nonvoting observer capacity, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that all information so provided shall be subject to Section 3.5 below and the Baillie Investors shall be responsible for any breaches of Section 3.5 by such representative with respect to such information; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. (f) As long as the Franklin Investors collectively hold at least 1,000,000 shares of Preferred Stock of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of the Franklin Investors to attend all meetings of its Board of Directors in a nonvoting observer capacity, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that all information so provided shall be subject to Section 3.5 below and the Franklin Investors shall be responsible for any breaches of Section 3.5 by such representative with respect to such information; provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest.

Appears in 1 contract

Sources: Investors’ Rights Agreement (Rapid Micro Biosystems, Inc.)

Observer Rights. (a) As long as Venrock owns not less than 50% of the shares of the Series B Preferred Stock it is purchasing under the Purchase Agreement or an equivalent amount of Common Stock issued upon conversion thereof (as adjusted for stock splits, stock combinations, stock dividends and the like), upon written request by ▇. ▇▇▇▇▇▇ Price Investors collectively hold at least 2,500,000 shares of Preferred Stock of to the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of ▇. ▇▇▇▇ Price such Investor acceptable to the Company to attend all meetings of its the Board of Directors (and any committee thereof) in a nonvoting observer capacitycapacity and, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that all information so provided shall be subject to Section 3.5 below and the ▇. ▇▇▇▇ Price Investors shall be responsible for any breaches of Section 3.5 by such representative with respect to such information; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. (b) As long as the Fidelity Investors collectively hold at least 2,500,000 shares of Preferred Stock of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of the Fidelity Investors to attend all meetings of its Board of Directors in a nonvoting observer capacity, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that all information so provided shall be subject to Section 3.5 below and the Fidelity Investors shall be responsible for any breaches of Section 3.5 by such representative with respect to such information; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. (c) As long as Maveron Equity Partners V, L.P. (“Maveron”) holds at least 10,000,000 shares of Preferred Stock of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of Maveron to attend all meetings of its Board of Directors in a nonvoting observer capacity, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that such representative shall agree to hold in confidence and maintain the confidentiality with respect to all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could would be reasonably likely to adversely affect the attorney-client privilege between the Company and its counsel or counsel, result in disclosure of trade secrets or highly confidential information, create a conflict of interestinterest or for other similar reasons. (db) As long as Tiger Global Private Investment Partners X, L.P. (“Tiger”) holds at least 2,500,000 Wellington owns not less than 50% of the shares of the Series B Preferred Stock it is purchasing under the Purchase Agreement or an equivalent amount of the Company, which number is subject to appropriate adjustment Common Stock issued upon conversion thereof (as adjusted for all stock splits, dividends, stock combinations, recapitalization stock dividends and the like), upon written request by ▇▇▇▇▇▇▇▇▇▇ to the Company, the Company shall invite a representative of Tiger such Investor acceptable to the Company to attend all meetings of its Board of Directors and any and all committees of its the Board of Directors (including and any Executive Committee, as defined in the Company’s bylawscommittee thereof) in a nonvoting observer capacitycapacity and, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors and/or committee membersdirectors; provided, however, that such representative shall agree to hold in confidence and maintain the confidentiality with respect to all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could would be reasonably likely to adversely affect the attorney-client privilege between the Company and its counsel or counsel, result in disclosure of trade secrets or highly confidential information, create a conflict of interestinterest or for other similar reasons. (e) As long as the Baillie Investors collectively hold at least 500,000 shares of Preferred Stock of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of the Baillie Investors to attend all meetings of its Board of Directors in a nonvoting observer capacity, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that all information so provided shall be subject to Section 3.5 below and the Baillie Investors shall be responsible for any breaches of Section 3.5 by such representative with respect to such information; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. (f) As long as the Franklin Investors collectively hold at least 1,000,000 shares of Preferred Stock of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of the Franklin Investors to attend all meetings of its Board of Directors in a nonvoting observer capacity, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that all information so provided shall be subject to Section 3.5 below and the Franklin Investors shall be responsible for any breaches of Section 3.5 by such representative with respect to such information; provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest.

Appears in 1 contract

Sources: Investor Rights Agreement (Metsera, Inc.)

Observer Rights. (a) As long as the ▇. ▇▇▇▇ Price Investors collectively Vivo Capital Fund IX, L.P. or its Affiliates (“Vivo Capital”) hold at least 2,500,000 any shares of Series B Preferred Stock of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the likeor Series C Preferred Stock, the Company shall invite a representative of ▇. ▇▇▇▇ Price Vivo Capital to attend all non-executive session meetings of its the Board of Directors in a nonvoting observer capacitycapacity and, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that all information so directors at the same time and in the same manner as provided shall be subject to Section 3.5 below and the ▇. ▇▇▇▇ Price Investors shall be responsible for any breaches of Section 3.5 by such representative with respect to such information; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. (b) As long as the Fidelity Investors collectively hold at least 2,500,000 shares of Preferred Stock of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of the Fidelity Investors to attend all meetings of its Board of Directors in a nonvoting observer capacity, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that all information so provided shall be subject to Section 3.5 below and the Fidelity Investors shall be responsible for any breaches of Section 3.5 by such representative with respect to such information; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. (c) As long as Maveron Equity Partners V, L.P. (“Maveron”) holds at least 10,000,000 shares of Preferred Stock of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of Maveron to attend all meetings of its Board of Directors in a nonvoting observer capacity, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that such representative shall agree to hold in confidence and maintain the confidentiality trust and to act in a fiduciary manner with respect to all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interestcounsel. (db) As long as Tiger Global Private Investment Partners X▇▇▇▇▇▇▇ Life Sciences IX, L.P. or its Affiliates (“Tiger▇▇▇▇▇▇▇”) holds at least 2,500,000 hold any shares of Series B Preferred Stock of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the likeor Series C Preferred Stock, the Company shall invite a representative of Tiger ▇▇▇▇▇▇▇ to attend all non-executive session meetings of its the Board of Directors and any and all committees of its Board of Directors (including any Executive Committee, as defined in the Company’s bylaws) in a nonvoting observer capacitycapacity and, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors and/or committee membersat the same time and in the same manner as provided to such directors; provided, however, that such representative shall agree to hold in confidence and maintain the confidentiality trust and to act in a fiduciary manner with respect to all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interestcounsel. (ec) As long as the Baillie Investors collectively hold at least 500,000 RTW holds any shares of Series C Preferred Stock of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the likeStock, the Company shall invite a representative of the Baillie Investors RTW to attend all non-executive session meetings of its the Board of Directors in a nonvoting observer capacitycapacity and, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors at the same time and in the same manner as provided to such directors; provided, however, that such representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided shall be subject to Section 3.5 below and the Baillie Investors shall be responsible for any breaches of Section 3.5 by such representative with respect to such informationprovided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interestcounsel. (f) As long as the Franklin Investors collectively hold at least 1,000,000 shares of Preferred Stock of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of the Franklin Investors to attend all meetings of its Board of Directors in a nonvoting observer capacity, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that all information so provided shall be subject to Section 3.5 below and the Franklin Investors shall be responsible for any breaches of Section 3.5 by such representative with respect to such information; provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest.

Appears in 1 contract

Sources: Investors’ Rights Agreement (Tarsus Pharmaceuticals, Inc.)

Observer Rights. (a) As long as the ▇. ▇▇▇▇ Price Investors collectively hold at least 2,500,000 Domain Partners VII, L.P. or its Affiliates (collectively, “Domain”) owns not less than 400,000 shares (appropriately adjusted for any stock split, dividend, combination or other recapitalization) of Preferred Stock (or an equivalent amount of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the likeCommon Stock issued upon conversion thereof), the Company shall invite a representative of Domain, initially ▇. ▇▇▇▇ Price ▇▇▇▇▇, to attend all meetings of its Board of Directors in a nonvoting observer capacitycapacity and, and in this respect, shall give such representative copies of all notices, minutes, consents, consents and other materials that it provides to its directors; provided, however, that such representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided shall be subject to Section 3.5 below and the ▇. ▇▇▇▇ Price Investors shall be responsible for any breaches of Section 3.5 by such representative with respect to such informationprovided; and and, provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-attorney client privilege between the Company and its counsel or would result in disclosure of trade secrets to such representative or if Domain or its representative is or is affiliated with a conflict direct competitor of interestthe Company. (b) As long as the Fidelity Investors collectively hold at least 2,500,000 ▇▇▇▇▇▇▇ Healthcare V, L.P. or its Affiliates (collectively, “▇▇▇▇▇▇▇”) owns not less than 400,000 shares (appropriately adjusted for any stock split, dividend, combination or other recapitalization) of Preferred Stock (or an equivalent amount of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the likeCommon Stock issued upon conversion thereof), the Company shall invite a representative of the Fidelity Investors ▇▇▇▇▇▇▇, initially ▇▇▇▇▇▇▇ ▇▇▇, to attend all meetings of its Board of Directors in a nonvoting observer capacitycapacity and, and in this respect, shall give such representative copies of all notices, minutes, consents, consents and other materials that it provides to its directors; provided, however, that such representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided shall be subject to Section 3.5 below and the Fidelity Investors shall be responsible for any breaches of Section 3.5 by such representative with respect to such informationprovided; and and, provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-attorney client privilege between the Company and its counsel or would result in disclosure of trade secrets to such representative or if ▇▇▇▇▇▇▇ or its representative is or is affiliated with a conflict direct competitor of interestthe Company. (c) As long as Maveron Equity Partners VCanaan VII, L.P. or its Affiliates (collectively, “MaveronCanaan”) holds at least 10,000,000 owns not less than 400,000 shares (appropriately adjusted for any stock split, dividend, combination or other recapitalization) of Preferred Stock (or an equivalent amount of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the likeCommon Stock issued upon conversion thereof), the Company shall invite a representative of Maveron Canaan, initially ▇▇▇▇▇ ▇▇▇▇▇▇, to attend all meetings of its Board of Directors in a nonvoting observer capacitycapacity and, and in this respect, shall give such representative copies of all notices, minutes, consents, consents and other materials that it provides to its directors; provided, however, that such representative shall agree to hold in confidence and maintain the confidentiality trust and to act in a fiduciary manner with respect to all information so provided; and and, provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-attorney client privilege between the Company and its counsel or would result in disclosure of trade secrets to such representative or if Canaan or its representative is or is affiliated with a conflict direct competitor of interestthe Company. (d) As long Any representative designated pursuant to this Section 3.9, above shall be required to enter into a confidentiality agreement containing substantially similar terms as Tiger Global Private Investment Partners X, L.P. (“Tiger”) holds at least 2,500,000 shares of Preferred Stock those set forth in Section 3.3 hereof with the Company prior to the exercise of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of Tiger to attend all meetings of its Board of Directors and any and all committees of its Board of Directors (including any Executive Committee, as defined in the Company’s bylaws) in a nonvoting observer capacity, and rights contained in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors and/or committee members; provided, however, that such representative shall agree to hold in confidence and maintain the confidentiality with respect to all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interestSection 3.9. (e) As long as the Baillie Investors collectively hold at least 500,000 shares of Preferred Stock of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of the Baillie Investors to attend all meetings of its Board of Directors in a nonvoting observer capacity, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that all information so provided shall be subject to Section 3.5 below and the Baillie Investors shall be responsible for any breaches of Section 3.5 by such representative with respect to such information; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. (f) As long as the Franklin Investors collectively hold at least 1,000,000 shares of Preferred Stock of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of the Franklin Investors to attend all meetings of its Board of Directors in a nonvoting observer capacity, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that all information so provided shall be subject to Section 3.5 below and the Franklin Investors shall be responsible for any breaches of Section 3.5 by such representative with respect to such information; provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest.

Appears in 1 contract

Sources: Investors’ Rights Agreement (Tobira Therapeutics, Inc.)

Observer Rights. (a) As long as Bay City Capital Fund V, L.P. owns not less than twenty-five percent 25% of the ▇. ▇▇▇▇ Price Investors collectively hold at least 2,500,000 shares of the Series C Preferred Stock it is purchasing under the Purchase Agreement (or an equivalent amount of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the likeCommon Stock issued upon conversion thereof), the Company shall invite a representative of ▇. ▇▇▇▇ Price Bay City Capital Fund V, L.P. to attend all meetings of its Board of Directors in a nonvoting observer capacitycapacity and, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that all information so provided shall be subject to Section 3.5 below and the ▇. ▇▇▇▇ Price Investors shall be responsible for any breaches of Section 3.5 by such representative with respect to such information; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. (b) As long as the Fidelity Investors collectively hold at least 2,500,000 shares of Preferred Stock of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of the Fidelity Investors to attend all meetings of its Board of Directors in a nonvoting observer capacity, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that all information so provided shall be subject to Section 3.5 below and the Fidelity Investors shall be responsible for any breaches of Section 3.5 by such representative with respect to such information; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. (c) As long as Maveron Equity Partners V, L.P. (“Maveron”) holds at least 10,000,000 shares of Preferred Stock of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of Maveron to attend all meetings of its Board of Directors in a nonvoting observer capacity, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that such representative shall agree to hold in confidence and maintain the confidentiality trust and to act in a fiduciary manner with respect to all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if such Investor or its representative is a competitor of the Company. (db) As long as Tiger Global Private Investment Partners XRA Capital Healthcare Fund, L.P. (“Tiger”) holds at least 2,500,000 LP owns not less than twenty-five percent 25% of the shares of the Series C Preferred Stock it is purchasing under the Purchase Agreement (or an equivalent amount of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the likeCommon Stock issued upon conversion thereof), the Company shall invite a representative of Tiger RA Capital Healthcare Fund, LP to attend all meetings of its Board of Directors and any and all committees of its Board of Directors (including any Executive Committee, as defined in the Company’s bylaws) in a nonvoting observer capacitycapacity and, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors and/or committee membersdirectors; provided, however, that such representative shall agree to hold in confidence and maintain the confidentiality trust and to act in a fiduciary manner with respect to all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. (e) As long as the Baillie Investors collectively hold at least 500,000 shares of Preferred Stock , or if such Investor or its representative is a competitor of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of the Baillie Investors to attend all meetings of its Board of Directors in a nonvoting observer capacity, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that all information so provided shall be subject to Section 3.5 below and the Baillie Investors shall be responsible for any breaches of Section 3.5 by such representative with respect to such information; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. (f) As long as the Franklin Investors collectively hold at least 1,000,000 shares of Preferred Stock of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of the Franklin Investors to attend all meetings of its Board of Directors in a nonvoting observer capacity, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that all information so provided shall be subject to Section 3.5 below and the Franklin Investors shall be responsible for any breaches of Section 3.5 by such representative with respect to such information; provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest.

Appears in 1 contract

Sources: Investors’ Rights Agreement (Civitas Therapeutics, Inc.)

Observer Rights. (a) As long as the ▇. ▇▇▇▇ Price Investors collectively hold at least 2,500,000 shares of Preferred Stock Investor owns not less than 50% of the Companyamount of Series B Preferred held by the Investor immediately following the Closing Date, which number is (subject to appropriate adjustment for all stock splits, stock dividends, combinations, recapitalization and combinations or the like), the Company Investor shall invite a representative of be entitled to have two representatives (who initially shall be ▇. ▇▇▇▇▇▇ Price to attend all meetings of its Board of Directors ▇▇▇▇▇ and ▇▇▇▇ Luck): (i) attend, in a nonvoting observer capacity, all meetings of the Board of Directors and (ii) receive, concurrently with the members of the Board of Directors and in this respectthe same manner, shall give such representative copies of all notices, minutes, consents, consents and other materials that it the Company provides to its directorsthe Board of Directors; provided, however, that all information so provided the Investor agrees to hold in confidence and trust and to act in a fiduciary manner, and shall be subject cause such representatives and their officers, directors, managing members, employees and agents to Section 3.5 below hold in confidence and the ▇. ▇▇▇▇ Price Investors shall be responsible for any breaches of Section 3.5 by such representative trust and to act in a fiduciary manner, with respect to such informationall information provided pursuant to this Section 2.4; and and, provided further, that the Company Board of Directors reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or would result in disclosure of trade secrets to such representative or if such representative is, or is affiliated with, a direct competitor of the Company. The representatives may also be excluded from portions of a meeting of the Board of Directors if, in the good faith judgment of the Board of Directors, the representatives have a conflict of interest. (b) As long as the Fidelity Investors collectively hold at least 2,500,000 shares of Preferred Stock of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of the Fidelity Investors to attend all meetings of its Board of Directors in a nonvoting observer capacity, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that all information so provided shall be subject to Section 3.5 below and the Fidelity Investors shall be responsible for any breaches of Section 3.5 by such representative interest with respect to such information; and provided furtherthe issue or issues to be discussed. The Company, that at its sole discretion, shall reimburse the Company reserves the right representatives for travel expenses incurred in attending Board of Director meetings, limited to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. (c) As long as Maveron Equity Partners V, L.P. (“Maveron”) holds at least 10,000,000 shares of Preferred Stock of reasonable levels consistent with the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of Maveron to attend all meetings of its Board of Directors in a nonvoting observer capacity, and ’s travel policies. The covenants set forth in this respect, Section 2.4 shall give such representative copies terminate and be of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that such representative shall agree to hold in confidence and maintain the confidentiality with respect to all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting no further force or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or effect upon a conflict of interest. (d) As long as Tiger Global Private Investment Partners X, L.P. (“Tiger”) holds at least 2,500,000 shares of Preferred Stock of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of Tiger to attend all meetings of its Board of Directors and any and all committees of its Board of Directors (including any Executive CommitteeLiquidation Event, as that term is defined in the Company’s bylaws) in a nonvoting observer capacity, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors and/or committee members; provided, however, that such representative shall agree to hold in confidence and maintain the confidentiality with respect to all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. (e) As long as the Baillie Investors collectively hold at least 500,000 shares of Series B Preferred Stock Certificate of the Company, which number is subject Designation (as amended from time to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of the Baillie Investors to attend all meetings of its Board of Directors in a nonvoting observer capacity, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that all information so provided shall be subject to Section 3.5 below and the Baillie Investors shall be responsible for any breaches of Section 3.5 by such representative with respect to such information; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interesttime). (f) As long as the Franklin Investors collectively hold at least 1,000,000 shares of Preferred Stock of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of the Franklin Investors to attend all meetings of its Board of Directors in a nonvoting observer capacity, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that all information so provided shall be subject to Section 3.5 below and the Franklin Investors shall be responsible for any breaches of Section 3.5 by such representative with respect to such information; provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest.

Appears in 1 contract

Sources: Investor's Rights Agreement (Players Network)

Observer Rights. (a) As long as Gilead (and its Affiliates, collectively) owns not less than fifty percent (50%) of the ▇. ▇▇▇▇ Price Investors collectively hold at least 2,500,000 shares of the Series B Preferred Stock it is purchasing under the Purchase Agreement (or an equivalent amount of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the likeCommon Stock issued upon conversion thereof), the Company shall invite a representative of ▇. ▇▇▇▇ Price Gilead to attend all regularly scheduled meetings of its the Board of Directors in a nonvoting observer capacitycapacity and, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that all information so provided shall be subject to Section 3.5 below at the Company’s request, the Company and the ▇. ▇▇▇▇ Price Investors shall be responsible for any breaches of Section 3.5 by such representative with respect shall enter into a confidentiality agreement in customary form reasonably acceptable to such informationGilead; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. (b) . As long as Redmile owns not less than fifty percent (50%) of the Fidelity Investors collectively hold at least 2,500,000 shares of the Series B Preferred Stock it is purchasing under the Purchase Agreement (or an equivalent amount of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the likeCommon Stock issued upon conversion thereof), the Company shall invite a representative of the Fidelity Investors Redmile to attend all regularly scheduled meetings of its the Board of Directors in a nonvoting observer capacitycapacity and, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that all information so provided shall be subject to Section 3.5 below and the Fidelity Investors shall be responsible for any breaches of Section 3.5 by such representative with respect to such information; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. (c) As long as Maveron Equity Partners V, L.P. (“Maveron”) holds at least 10,000,000 shares of Preferred Stock of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of Maveron to attend all meetings of its Board of Directors in a nonvoting observer capacity, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that such representative shall agree to hold in confidence and maintain the confidentiality trust and to act in a fiduciary manner with respect to all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of competitive information, trade secrets or a conflict of interest. (d) As long as Tiger Global Private Investment Partners X, L.P. (“Tiger”) holds at least 2,500,000 shares of Preferred Stock of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of Tiger to attend all meetings of its Board of Directors and any and all committees of its Board of Directors (including any Executive Committee, as defined in the Company’s bylaws) in a nonvoting observer capacity, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors and/or committee members; provided, however, that such representative shall agree to hold in confidence and maintain the confidentiality with respect to all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. (e) As long as the Baillie Investors collectively hold at least 500,000 shares of Preferred Stock of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of the Baillie Investors to attend all meetings of its Board of Directors in a nonvoting observer capacity, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that all information so provided shall be subject to Section 3.5 below and the Baillie Investors shall be responsible for any breaches of Section 3.5 by such representative with respect to such information; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. (f) As long as the Franklin Investors collectively hold at least 1,000,000 shares of Preferred Stock of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of the Franklin Investors to attend all meetings of its Board of Directors in a nonvoting observer capacity, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that all information so provided shall be subject to Section 3.5 below and the Franklin Investors shall be responsible for any breaches of Section 3.5 by such representative with respect to such information; provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest.

Appears in 1 contract

Sources: Investors’ Rights Agreement (Allovir, Inc.)

Observer Rights. (a) As long as the ▇. ▇▇▇▇ Price Investors collectively hold at least 2,500,000 shares of Preferred Stock Investor owns any portion of the Company, which number Convertible Notes or the Warrants it is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and purchasing under the likePurchase Agreement, the Company shall invite a representative of ▇. ▇▇▇▇ Price the Investor to attend all meetings of its Board of Directors in a nonvoting observer capacitycapacity and, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that all information so directors at the same time and in the same manner as provided shall be subject to Section 3.5 below and the ▇. ▇▇▇▇ Price Investors shall be responsible for any breaches of Section 3.5 by such representative with respect to such information; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. (b) As long as the Fidelity Investors collectively hold at least 2,500,000 shares of Preferred Stock of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of the Fidelity Investors to attend all meetings of its Board of Directors in a nonvoting observer capacity, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that all information so provided shall be subject to Section 3.5 below and the Fidelity Investors shall be responsible for any breaches of Section 3.5 by such representative with respect to such information; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. (c) As long as Maveron Equity Partners V, L.P. (“Maveron”) holds at least 10,000,000 shares of Preferred Stock of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of Maveron to attend all meetings of its Board of Directors in a nonvoting observer capacity, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that such representative shall agree to hold in confidence and maintain the confidentiality trust and to act in a fiduciary manner with respect to all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting will, in the opinion of counsel, could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. (d) As long as Tiger Global Private Investment Partners X, L.P. (“Tiger”) holds at least 2,500,000 shares of Preferred Stock of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of Tiger to attend all meetings of its Board of Directors and any and all committees of its Board of Directors (including any Executive Committee, as defined in interest or would adversely affect the Company’s bylawsrelationship with its senior lenders. Notwithstanding the foregoing, upon the conversion of all or any portion of any Convertible Note into Common Stock or the exercise of all or any portion of the Warrants into Series A Preferred Stock, then the Investor shall at all times be entitled to elect one (1) director of the Company (the “Investor Director”). Any Investor Director elected as provided in a nonvoting observer capacitythis Section 3.5 may be removed with or without cause by, and in only by, the affirmative vote of the Investor given either at a special meeting called for that purpose or pursuant to a written consent of the Investor. If the Investor Director is elected then all other Investor observer rights pursuant to this respect, Section 3.5 shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors and/or committee membersterminate; provided, however, that such representative that, subject to Section 3.3, the observer rights set forth in this Section 3.5 shall agree revive in all respects in the event an Investor Director ceases to hold in confidence serve on the Board of Directors for any reason and maintain the confidentiality with respect Investor continues to all information so provided; and provided further, that the Company reserves the right to withhold own any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. (e) As long as the Baillie Investors collectively hold at least 500,000 shares of Preferred Stock of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of the Baillie Investors to attend all meetings of its Board of Directors in a nonvoting observer capacity, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directorsor Common Stock; provided, however, that all information so provided shall be subject to Section 3.5 below and the Baillie Investors shall be responsible for any breaches of Section 3.5 by such representative with respect to such information; and provided further, that such observer rights shall similarly terminate upon a successor Investor Director being elected to the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. (f) As long as the Franklin Investors collectively hold at least 1,000,000 shares of Preferred Stock of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of the Franklin Investors to attend all meetings of its Board of Directors in a nonvoting observer capacity, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that all information so provided shall be subject to Section 3.5 below and the Franklin Investors shall be responsible for any breaches of Section 3.5 by such representative with respect to such information; provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interestDirectors.

Appears in 1 contract

Sources: Investor’s Rights Agreement (Digital Domain Media Group, Inc.)

Observer Rights. (a) 2.3.1 As long as the ▇. ▇▇▇▇ Price Investors collectively hold Vivo and its Affiliates continue to own beneficially at least 2,500,000 3,590,664 shares of the Series C-1 Preferred Stock it purchased under the Series C Purchase Agreement (or an equivalent amount of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the likeCommon Stock issued upon conversion thereof), the Company shall invite a representative of ▇. ▇▇▇▇ Price Vivo to attend all meetings of its Board of Directors in a nonvoting observer capacitycapacity and, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that all information so directors at the same time and in the same manner as provided shall be subject to Section 3.5 below and the ▇. ▇▇▇▇ Price Investors shall be responsible for any breaches of Section 3.5 by such representative with respect to such information; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. (b) As long as the Fidelity Investors collectively hold at least 2,500,000 shares of Preferred Stock of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of the Fidelity Investors to attend all meetings of its Board of Directors in a nonvoting observer capacity, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that all information so provided shall be subject to Section 3.5 below and the Fidelity Investors shall be responsible for any breaches of Section 3.5 by such representative with respect to such information; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. (c) As long as Maveron Equity Partners V, L.P. (“Maveron”) holds at least 10,000,000 shares of Preferred Stock of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of Maveron to attend all meetings of its Board of Directors in a nonvoting observer capacity, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that such representative shall agree in writing to hold be bound by the provisions of Section 2.4 below and to act in confidence and maintain the confidentiality a fiduciary manner with respect to all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or counsel, result in disclosure of trade secrets or a conflict of interest. (d) As long as Tiger Global Private Investment Partners X, L.P. (“Tiger”) holds at least 2,500,000 shares of Preferred Stock if such Investor or its representative is a competitor of the Company, which number is subject or to appropriate adjustment protect confidential or proprietary information of a third party or for all stock splits, dividends, combinations, recapitalization other similar reasons. 2.3.2 As long as 5AM and its Affiliates continue to own beneficially at least 3,590,664 shares of the likeSeries C-1 Preferred Stock it purchased under the Series C Purchase Agreement (or an equivalent amount of Common Stock issued upon conversion thereof), the Company shall invite a representative of Tiger 5AM to attend all meetings of its Board of Directors and any and all committees of its Board of Directors (including any Executive Committee, as defined in the Company’s bylaws) in a nonvoting observer capacitycapacity and, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors and/or committee membersat the same time and in the same manner as provided to such directors; provided, however, that such representative shall agree in writing to hold be bound by the provisions of Section 2.4 below and to act in confidence and maintain the confidentiality a fiduciary manner with respect to all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or counsel, result in disclosure of trade secrets or a conflict of interest. (e) As long as the Baillie Investors collectively hold at least 500,000 shares of Preferred Stock , if such Investor or its representative is a competitor of the Company, which number is subject or to appropriate adjustment protect confidential or proprietary information of a third party or for all stock splits, dividends, combinations, recapitalization other similar reasons. 2.3.3 As long as venBio and its Affiliates continue to own beneficially at least 3,590,664 shares of the likeSeries C-1 Preferred Stock it purchased under the Series C Purchase Agreement (or an equivalent amount of Common Stock issued upon conversion thereof), the Company shall invite a representative of the Baillie Investors venBio to attend all meetings of its Board of Directors in a nonvoting observer capacitycapacity and, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors at the same time and in the same manner as provided to such directors; provided, however, that such representative shall agree in writing to be bound by the provisions of Section 2.4 below and to act in a fiduciary manner with respect to all information so provided shall be subject to Section 3.5 below and the Baillie Investors shall be responsible for any breaches of Section 3.5 by such representative with respect to such informationprovided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or counsel, result in disclosure of trade secrets or a conflict of interest. (f) As long as the Franklin Investors collectively hold at least 1,000,000 shares of Preferred Stock , if such Investor or its representative is a competitor of the Company, which number is subject or to appropriate adjustment protect confidential or proprietary information of a third party or for all stock splits, dividends, combinations, recapitalization other similar reasons. 2.3.4 As long as Norwest and its Affiliates continue to own beneficially at least 2,586,141 shares of the likeSeries D Preferred Stock it purchased under the Purchase Agreement (or an equivalent amount of Common Stock issued upon conversion thereof), the Company shall invite a representative of the Franklin Investors Norwest to attend all meetings of its Board of Directors in a nonvoting observer capacitycapacity and, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors at the same time and in the same manner as provided to such directors; provided, however, that such representative shall agree in writing to be bound by the provisions of Section 2.4 below and to act in a fiduciary manner with respect to all information so provided shall be subject to Section 3.5 below provided; and the Franklin Investors shall be responsible for any breaches of Section 3.5 by such representative with respect to such information; provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or counsel, result in disclosure of trade secrets or a conflict of interest, if such Investor or its representative is a competitor of the Company, or to protect confidential or proprietary information of a third party or for other similar reasons. 2.3.5 As long as KKR and its Affiliates continue to own beneficially at least 2,586,141 shares of the Series D Preferred Stock it purchased under the Purchase Agreement (or an equivalent amount of Common Stock issued upon conversion thereof), the Company shall invite a representative of KKR to attend all meetings of its Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors at the same time and in the same manner as provided to such directors; provided, however, that such representative shall agree in writing to be bound by the provisions of Section 2.4 below and to act in a fiduciary manner with respect to all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel, result in disclosure of trade secrets or a conflict of interest, if such Investor or its representative is a competitor of the Company, or to protect confidential or proprietary information of a third party or for other similar reasons.

Appears in 1 contract

Sources: Investors’ Rights Agreement (Impel Neuropharma Inc)

Observer Rights. (a) As long as Atlas owns not less than 25% of the ▇. ▇▇▇▇ Price Investors collectively hold at least 2,500,000 shares of the Preferred Stock owned by it on or after the date hereof, including shares of Series B Preferred Stock it is purchasing under the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the likePurchase Agreement (or an equivalent amount of Common Stock issued upon conversion thereof), the Company shall invite a representative of ▇. ▇▇▇▇ Price Atlas to attend all meetings of its the Board of Directors (and any committee thereof) in a nonvoting observer capacitycapacity and, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that all information so directors at the same time and in the same manner as provided shall be subject to Section 3.5 below and the ▇. ▇▇▇▇ Price Investors shall be responsible for any breaches of Section 3.5 by such representative with respect to such information; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. (b) As long as the Fidelity Investors collectively hold at least 2,500,000 shares of Preferred Stock of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of the Fidelity Investors to attend all meetings of its Board of Directors in a nonvoting observer capacity, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that all information so provided shall be subject to Section 3.5 below and the Fidelity Investors shall be responsible for any breaches of Section 3.5 by such representative with respect to such information; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. (c) As long as Maveron Equity Partners V, L.P. (“Maveron”) holds at least 10,000,000 shares of Preferred Stock of the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the like, the Company shall invite a representative of Maveron to attend all meetings of its Board of Directors in a nonvoting observer capacity, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that such representative shall agree to hold in confidence and maintain the confidentiality with respect to all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. The Company shall reimburse the Atlas representative for all reasonable out-of-pocket travel expenses incurred (consistent with the Company’s travel policy) in connection with attending meetings of the Board of Directors. (db) As long as Tiger Global Private Investment Partners X, L.P. (“Tiger”) holds at least 2,500,000 Northpond owns not less than 25% of the shares of the Preferred Stock owned by it on or after the date hereof, including shares of Series B Preferred Stock it is purchasing under the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the likePurchase Agreement (or an equivalent amount of Common Stock issued upon conversion thereof), the Company shall invite a representative of Tiger Northpond to attend all meetings of its Board of Directors and any and all committees of its the Board of Directors (including and any Executive Committee, as defined in the Company’s bylawscommittee thereof) in a nonvoting observer capacitycapacity and, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors and/or committee membersat the same time and in the same manner as provided to such directors; provided, however, that such representative shall agree to hold in confidence and maintain the confidentiality with respect to all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. The Company shall reimburse the Northpond representative for all reasonable out-of-pocket travel expenses incurred (consistent with the Company’s travel policy) in connection with attending meetings of the Board of Directors. (ec) As long as Hatteras owns not less than 25% of the Baillie Investors collectively hold at least 500,000 shares of the Preferred Stock owned by it on or after the date hereof, including shares of Series B Preferred Stock it is purchasing under the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the likePurchase Agreement (or an equivalent amount of Common Stock issued upon conversion thereof), the Company shall invite a representative of the Baillie Investors Hatteras to attend all meetings of its the Board of Directors (and any committee thereof) in a nonvoting observer capacitycapacity and, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors at the same time and in the same manner as provided to such directors; provided, however, that such representative shall agree to hold in confidence all information so provided shall be subject to Section 3.5 below and the Baillie Investors shall be responsible for any breaches of Section 3.5 by such representative with respect to such informationprovided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. The Company shall reimburse the Hatteras representative for all reasonable out-of-pocket travel expenses incurred (consistent with the Company’s travel policy) in connection with attending meetings of the Board of Directors. (fd) As long as Vida owns not less than 25% of the Franklin Investors collectively hold at least 1,000,000 shares of the Preferred Stock owned by it on or after the date hereof, including shares of Series B Preferred Stock it is purchasing under the Company, which number is subject to appropriate adjustment for all stock splits, dividends, combinations, recapitalization and the likePurchase Agreement (or an equivalent amount of Common Stock issued upon conversion thereof), the Company shall invite a representative of the Franklin Investors Vida to attend all meetings of its the Board of Directors (and any committee thereof) in a nonvoting observer capacitycapacity and, and in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that all information so provided shall be subject to Section 3.5 below and the Franklin Investors shall be responsible for any breaches of Section 3.5 by such representative with respect to such information; provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest.directors at

Appears in 1 contract

Sources: Investors’ Rights Agreement (Vigil Neuroscience, Inc.)